Seminars in Nuclear Medicine
Volume 37, Issue 6 , Pages 462-469 , November 2007

18F-Fluoride Positron Emission Tomography and Positron Emission Tomography/Computed Tomography

  • Einat Even-Sapir, MD, PhD

      Affiliations

    • Department of Nuclear Medicine, Osteoradioiology Unit, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
    • Corresponding Author InformationAddress reprint requests to Einat Even-Sapir, MD, PhD, Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, 6 Weizman Street, Tel-Aviv 64239, Israel.
  • ,
  • Eyal Mishani, PhD

      Affiliations

    • The Cyclotron Unit, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • ,
  • Gideon Flusser, MD

      Affiliations

    • Department of Radiology, Osteoradioiology Unit, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • ,
  • Ur Metser, MD

      Affiliations

    • Department of Nuclear Medicine, Osteoradioiology Unit, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

References 

  1. Blau M, Nagler W, Bender MA. A new isotope for bone scanning. J Nucl Med. 1962;3:332–334
  2. Blau M, Ganatra R, Bender MA. 18F-fluoride for bone imaging. Semin Nucl Med. 1972;2:31–37
  3. Hawkins RA, Choi Y, Huang SC, et al. Evaluation of skeletal kinetics of fluorine 18-fluoride ion and PET. J Nucl Med. 1992;33:633–642
  4. Schiepers C, Nuyts J, Bormans G, et al. Fluoride kinetics of the axial skeleton measured in vivo with fluorine-18-fluoride PET. J Nucl Med. 1997;38:1970–1976
  5. Blake GM, Park-Holoan SJ, Cook GJR, et al. Quantitative studies of bone with the use of F18-fluoride and Tc99m-methylene diphosphonate. Semin Nucl Med. 2001;1:28–49
  6. Wootton R, Dore C. The single-passage extraction of 18F in rabbit bone. Clin Physiol Meas. 1986;7:333–343
  7. Hoh CK, Hawkins RA, Dahlbom M, et al. Whole body skeletal imaging with (18F) fluoride ion and PET. J Comput Assist Tomogr. 1993;17:34–41
  8. Toegel S, Hoffmann O, Wadsak W, et al. Uptake of bone-seekers is solely associated with mineralization (A study with 99mTc-MDP, 153Sm-EDTMP and 18F-fluoride on osteoblasts). Eur J Nucl Med Mol Imaging. 2006;33:491–494
  9. Ishiguro K, Nakagaki H, Tsuboi S, et al. Distribution of fluoride in cortical bone of human rib. Calcif Tissue Int. 1993;52:278–282
  10. Messa C, Goodman WG, Hoh CK, et al. Bone metabolic activity measured with positron emission tomography and [18F]fluoride ion in renal osteodystrophy: correlation with bone histomorphometry. J Clin Endocrinol Metab. 1993;77:949–955
  11. Berding G, Burchert W, van den Hoff J, et al. Evaluation of the incorporation of bone grafts used in maxillofacial surgery with [18F]fluoride ion and dynamic positron emission tomography. Eur J Nucl Med. 1995;22:1133–1140
  12. Schiepers C, Broos P, Miserez M, et al. Measurement of skeletal flow with positron emission tomography and 18F-fluoride in femoral head osteonecrosis. Arch Orthop Trauma Surg. 1998;118:131–135
  13. Piert M, Winter E, Becker GA, et al. Allogenic bone graft viability after hip revision arthroplasty assessed by dynamic [18F]fluoride ion positron emission tomography. Eur J Nucl Med. 1999;26:615–624
  14. Schliephake H, Berding G, Knapp WH, et al. Monitoring of graft perfusion and osteoblast activity in revascularised fibula segments using [18F]-positron emission tomography. Int J Oral Maxillofac Surg. 1999;28:349–355
  15. Frost ML, Cook GJ, Blake GM, et al. A prospective study of risedronate on regional bone metabolism and blood flow at the lumbar spine measured by 18F-fluoride positron emission tomography. J Bone Miner Res. 2003;18:2215–2222
  16. Cook GJ, Lodge MA, Blake GM, et al. Differences in skeletal kinetics between vertebral and humeral bone measured by 18F-fluoride positron emission tomography in postmenopausal women. J Bone Miner Res. 2000;15:763–769
  17. Forrest N, Welch A, Murray AD, et al. Emoral head viability after Birmingham resurfacing hip arthroplasty: Assessment with use of [18F] fluoride positron emission tomography. J Bone Joint Surg Am. 2006;88(Suppl):84–89
  18. Piert M, Zittel TT, Becker GA, et al. Assessment of porcine bone metabolism by dynamic [18F]fluoride ion PET: Correlation with bone histomorphometry. J Nucl Med. 2001;42:1091–1100
  19. Cook GJ, Blake GM, Marsden PK, et al. Quantification of skeletal kinetic indices in Paget’s disease using dynamic 18F-fluoride positron emission tomography. J Bone Miner Res. 2002;17:854–859
  20. Frost ML, Fogelman I, Blake GM, et al. Dissociation between global markers of bone formation and direct measurement of spinal bone formation in osteoporosis. J Bone Miner Res. 2004;19:1797–1804
  21. Berding G, Schliephake H, van den Hoff J, et al. Assessment of the incorporation of revascularized fibula grafts used for mandibular reconstruction with F-18-PET. Nuklearmedizin. 2001;40:51–58
  22. Hsu WK, Feeley BT, Krenek L, et al: The use of (18)F-fluoride and (18)F-FDG PET scans to assess fracture healing in a rat femur model. Eur J Nucl Med Mol Imaging, in press
  23. Brenner W, Vernon C, Conrad EU, et al. Assessment of the metabolic activity of bone grafts with (18)F-fluoride PET. Eur J Nucl Med Mol Imaging. 2004;31:1291–1298
  24. Installé J, Nzeusseu A, Bol A, et al. (18)F-fluoride PET for monitoring therapeutic response in Paget’s disease of bone. J Nucl Med. 2005;46:1650–1658
  25. Sörensen J, Michaelsson K, Strand H, et al. Long-standing increased bone turnover at the fixation points after anterior cruciate ligament reconstruction: A positron emission tomography (PET) study of 8 patients. Acta Orthop. 2006;77:921–925
  26. Ullmark G, Sörensen J, Långström B, et al. Bone regeneration 6 years after impaction bone grafting: A PET analysis. Acta Orthop. 2007;78:201–205
  27. Petren-Mallmin M, Andrasson I, Ljunggren O, et al. Skeletal metastases from breast cancer: Uptake of F18-fluoride measured with positron emission tomography in correlation with CT. Skelet Radiol. 1998;27:72–76
  28. Hoegerle S, Juengling F, Otte A, et al. Combined FDG and F-18-fluoride whole body PET: A feasible two-in-one approach to cancer imaging. Radiology. 1998;209:253–258
  29. Schirrmeister H, Guhlmann A, Elsner K, et al. Sensitivity in detecting osseous lesions depends on anatomic localization: Planar bone scintigraphy versus 18F PET. J Nucl Med. 1999;40:1623–1629
  30. Schirrmeister H, Guhlnamm A, Kotzerke J, et al. Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol. 1999;17:2381–2389
  31. Cook GJ, Fogelman I. The role of positron emission tomography in the management of bone metastases. Cancer. 2000;88:2927–2933
  32. Schirmeister H, Glatting G, Hetzel J, et al. Prospective evaluation of clinical value of planar bone scan, SPECT and 18F-labeled NaF PET in newly diagnosed lung cancer. J Nucl Med. 2001;42:1800–1804
  33. Cook GJ, Fogelman I. The role of positron emission tomography in skeletal disease. Semin Nucl Med. 2001;3:50–61
  34. Wahl RL. Current status of PET in breast cancer imaging, staging, and therapy. Semin Roentgenol. 2001;36:250–260
  35. Hetzel M, Arslandemir C, König HH, et al. F-18 NaF PET for detection of bone metastases in lung cancer: Accuracy, cost-effectiveness, and impact on patient management. J Bone Miner Res. 2003;18:2206–2214
  36. Even-Sapir E, Metser U, Flusser G, et al. Assessment of malignant skeletal disease with 18F-Fluoride PET/CT. J Nucl Med. 2004;45:272–278
  37. Even-Sapir E. Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities. J Nucl Med. 2005;46:1356–1367
  38. Eubank WB, Mankoff DA. Current and future uses of positron emission tomography in breast cancer imaging. Semin Nucl Med. 2004;34:224–240
  39. Schoder H, Larson SM. Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med. 2004;34:274–292
  40. Fogelman I, Cook G, Israel O, Van der Wall H. Positron emission tomography and bone metastases. Semin Nucl Med. 2005;35:135–142
  41. Even-Sapir E, Metser U, Mishani E, et al. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. J Nucl Med. 2006;47:287–297
  42. Langsteger W, Heinisch M, Fogelman I. The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast. Semin Nucl Med. 2006;36:73–92
  43. Ovadia D, Metser U, Lievshitz G, et al. Back pain in adolescents: Assessment with integrated 18F-fluoride positron-emission tomography-computed tomography. J Pediatr Orthop. 2007;27:90–93
  44. Lim R, Fahey FH, Drubach LA, et al. Early experience with fluorine-18 sodium fluoride bone PET in young patients with back pain. J Pediatr Orthop. 2007;27:277–282
  45. Sterner T, Pink R, Freudenberg L, et al. The role of [18F]fluoride positron emission tomography in the early detection of aseptic loosening of total knee arthroplasty. Int J Surg. 2007;5:99–104
  46. Tayama Y, Takahashi N, Oka T, et al. Clinical evaluation of the effect of attenuation correction technique on 18F-fluoride PET images. Ann Nucl Med. 2007;21:93–99
  47. Brix G, Lechel U, Glatting G, et al. Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations. J Nucl Med. 2005;46:608–613
  48. Fahey FH, Palmer MR, Strauss KJ, et al. Dosimetry and adequacy of CT-based attenuation correction for pediatric PET: Phantom study. Radiology. 2007;243:96–104
  49. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 1983;3:1–7
  50. Brenner W, Vernon C, Muzi M, et al. Comparison of different quantitative approaches to 18F-fluoride PET scans. J Nucl Med. 2004;45:1493–1500

PII: S0001-2998(07)00085-2

doi: 10.1053/j.semnuclmed.2007.07.002

Seminars in Nuclear Medicine
Volume 37, Issue 6 , Pages 462-469 , November 2007